XIAMEN, China, March 30, 2026 /PRNewswire/ -- Akuvox, a global leading provider of smart intercom and smart home products and solutions, is proud to announce that the X937, its premier 15.6" Surveillance + Intercom AI Monitor, has been honored with the prestigious iF Design Award 2026 for the User Experience(UX) discipline. This global recognition celebrates the seamless fusion of elite UX design with cutting-edge smart intercom technology.
The Akuvox X937 redefines the boundaries of smart intercom monitors. As a professional security hub, it integrates comprehensive surveillance and intelligent intercom via its 15.6-inch display. Featuring AI voice interaction, it ensures a seamless experience for all users. Rooted in clarity, trust, and intuitive control, X937's large-screen UX and optimized hierarchy minimize the learning curve, making complex security data clear at a glance.
So, how exactly does X937 achieve these advancements?
Seamless NVR and Surveillance Integration via One Smart Intercom Monitor
The X937 acts as a centralized surveillance hub, integrating with third-party NVRs to display up to 25 live feeds on its 15.6-inch screen. It empowers users to manage comprehensive video surveillance alongside real-time video calls and door access from a single, centralized hub. Crucially, the integration of third-party NVRs significantly enhances residents' situational awareness, elevating home security to a more proactive level.
LLM-Powered AI Voice Assistant for Intuitive Intercom Control
Equipped with an LLM-powered AI voice assistant, Akuvox X937 enables natural language interaction. This intuitive, easy-to-use control eliminates the learning curve, making advanced intercom management accessible to everyone.
Android 14 GMS Certification: Smart Intercom Ecosystem Extensibility
As one of the few Android 14 intercoms certified by Google Mobile Service(GMS), the X937 integrates with the vast Android ecosystem. Users can unlock millions of apps via Google Play, transforming it into a streaming hub, cooking assistant, or music player—redefining smart intercom boundaries.
High-Performance Intercom Hardware: 6 TOPS NPU and Audiovisual Excellence
X937's 15.6-inch 1080P ultra-narrow bezel display provides a truly immersive experience. An integrated 6 TOPS NPU ensures seamless third-party app performance, while a quad-mic and speaker array maintains crystal-clear communication, even in noisy environments.
Akuvox X937 transcends traditional intercoms, consolidating 25-channel NVR surveillance, AI voice interaction, and the GMS-certified Android 14 ecosystem into a 15.6-inch platform. This blend of professional security and versatile extensibility establishes the X937 as a future-proof benchmark for modern, secure, and intelligent intercom monitors.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Celebrating Design Excellence: Akuvox's X937 Surveillance + Intercom AI Monitor Clinches the iF Design Award 2026
|
Nairobi event takes place May 7-9
STOCKHOLM, March 30, 2026 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) – is convening the first-ever regional summit dedicated exclusively to psoriasis in Africa - one of the continent's most underrecognized chronic diseases.
Key Highlights:
- First Africa Forum on Psoriasis: May 7–9, Nairobi, bringing together global and local stakeholders.
- Huge unmet need: 3.5M+ Africans affected, with limited care, stigma, and devastating economic impact.
- Focus areas: Local research, patient representation, and improved access to treatment.
The IFPA Forum Africa 2026 – Local Strength, United Action will take place on 7-9 May 2026 in Nairobi, Kenya, and will bring together policymakers, clinicians, researchers, and patient organizations to address a condition that remains severely under-recognized and underdiagnosed across the continent.
The Hidden Burden of Psoriasis in Africa
Psoriasis and psoriatic arthritis are chronic non-communicable diseases with no cure that can cause pain, disability, and are closely linked to other serious NCDs, like diabetes, obesity, cardiovascular disease, depression, and more. As a condition, visible on the skin, it often leads to stigma, affects mental health and can also cause economic hardship. Yet across Africa it remains under-recognized, underdiagnosed, and undertreated.
Over 3.5 million people are estimated to live with psoriasis across Africa – a continent of approximately 1.3 billion population. As experts warn the real psoriasis burden is likely higher due to limited epidemiological data, low awareness of the disease and severe shortages of specialists. Reported prevalence in parts of East, West, Central, and Southern Africa is as low as 0.06%, reflecting widespread underdiagnosis.
Access to Care and Economic Impact
Access to care is extremely limited: there is one dermatologist per more than a million people in Africa, compared with 36 per million in the United States and 65 per million in Germany. With most care paid out of pocket, treatment for psoriasis is often unaffordable, meaning the disease can become a pathway into poverty for those affected and their families.
To drive change, IFPA is convening regional and global stakeholders at this first-of-its-kind Forum, working alongside patient organizations like PsorAfrica to create a roadmap for tackling psoriasis in Africa.
Frida Dunger, Executive Director of IFPA, said:
"Psoriasis is a public health challenge. Addressing it is not optional — it is part of building resilient, equitable health systems. Every year, IFPA Forum puts focus on a region at a time, bringing together local stakeholders to inspire advocacy efforts and call for united action on psoriasis. This year, we bring the Forum to Africa, and we believe the timing is right. By listening to local patient organizations and developing a roadmap for tackling psoriasis in Africa together, we can ensure that millions of people living with psoriasis are finally seen, heard, and supported."
"Whether in the rural areas or in the cities, people in Africa do not know enough about psoriasis. And it affects my life. The cost, the worry, the impact on my life choices and social relationships. At the Forum, we are gathering experts who understand this disease and stand up for a better future. Africa is prioritizing health, and we will be a part of building solutions, - said Pierre Celestin Habiyaremye, President of PsorAfrica and Founder of Rwanda Psoriasis and Psoriatic Arthritis Organization.
Janet Mbugua, a prominent Kenyan media professional and advocate for social change, has confirmed that she will host the Forum. She said:
"I'm truly honored to host the IFPA Forum Africa. Psoriasis affects millions of people, yet it's still not spoken about enough. This is an opportunity to bring those stories to the forefront, shed light on the real challenges people are facing, and support the work being done locally to strengthen care, research, and policy across the continent."
The Forum will focus on three urgent priorities:
- research - to generate local data on psoriasis
- representation - to ensure patient voices shape decisions about healthcare
- rights and access - to integrate psoriasis into national NCD strategies, include essential medicines, and combat stigma.
About IFPA
IFPA (the International Federation of Psoriasis Associations), founded in 1971 and based in Stockholm, Sweden, is the global organization dedicated to advocating for everyone affected by psoriatic disease. IFPA's members include national and regional patient associations and represent over 60 million people worldwide. Through global coalitions, World Psoriasis Day campaigns, the IFPA Forum, and the World Psoriasis & Psoriatic Arthritis Conference, IFPA is redefining psoriatic disease as a key lens for stronger, more inclusive health systems.
https://www.ifpa-pso.com/
Nairobi event takes place May 7-9
STOCKHOLM, March 30, 2026 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) – is convening the first-ever regional summit dedicated exclusively to psoriasis in Africa - one of the continent's most underrecognized chronic diseases.
Key Highlights:
- First Africa Forum on Psoriasis: May 7–9, Nairobi, bringing together global and local stakeholders.
- Huge unmet need: 3.5M+ Africans affected, with limited care, stigma, and devastating economic impact.
- Focus areas: Local research, patient representation, and improved access to treatment.
The IFPA Forum Africa 2026 – Local Strength, United Action will take place on 7-9 May 2026 in Nairobi, Kenya, and will bring together policymakers, clinicians, researchers, and patient organizations to address a condition that remains severely under-recognized and underdiagnosed across the continent.
The Hidden Burden of Psoriasis in Africa
Psoriasis and psoriatic arthritis are chronic non-communicable diseases with no cure that can cause pain, disability, and are closely linked to other serious NCDs, like diabetes, obesity, cardiovascular disease, depression, and more. As a condition, visible on the skin, it often leads to stigma, affects mental health and can also cause economic hardship. Yet across Africa it remains under-recognized, underdiagnosed, and undertreated.
Over 3.5 million people are estimated to live with psoriasis across Africa – a continent of approximately 1.3 billion population. As experts warn the real psoriasis burden is likely higher due to limited epidemiological data, low awareness of the disease and severe shortages of specialists. Reported prevalence in parts of East, West, Central, and Southern Africa is as low as 0.06%, reflecting widespread underdiagnosis.
Access to Care and Economic Impact
Access to care is extremely limited: there is one dermatologist per more than a million people in Africa, compared with 36 per million in the United States and 65 per million in Germany. With most care paid out of pocket, treatment for psoriasis is often unaffordable, meaning the disease can become a pathway into poverty for those affected and their families.
To drive change, IFPA is convening regional and global stakeholders at this first-of-its-kind Forum, working alongside patient organizations like PsorAfrica to create a roadmap for tackling psoriasis in Africa.
Frida Dunger, Executive Director of IFPA, said:
"Psoriasis is a public health challenge. Addressing it is not optional — it is part of building resilient, equitable health systems. Every year, IFPA Forum puts focus on a region at a time, bringing together local stakeholders to inspire advocacy efforts and call for united action on psoriasis. This year, we bring the Forum to Africa, and we believe the timing is right. By listening to local patient organizations and developing a roadmap for tackling psoriasis in Africa together, we can ensure that millions of people living with psoriasis are finally seen, heard, and supported."
"Whether in the rural areas or in the cities, people in Africa do not know enough about psoriasis. And it affects my life. The cost, the worry, the impact on my life choices and social relationships. At the Forum, we are gathering experts who understand this disease and stand up for a better future. Africa is prioritizing health, and we will be a part of building solutions, - said Pierre Celestin Habiyaremye, President of PsorAfrica and Founder of Rwanda Psoriasis and Psoriatic Arthritis Organization.
Janet Mbugua, a prominent Kenyan media professional and advocate for social change, has confirmed that she will host the Forum. She said:
"I'm truly honored to host the IFPA Forum Africa. Psoriasis affects millions of people, yet it's still not spoken about enough. This is an opportunity to bring those stories to the forefront, shed light on the real challenges people are facing, and support the work being done locally to strengthen care, research, and policy across the continent."
The Forum will focus on three urgent priorities:
- research - to generate local data on psoriasis
- representation - to ensure patient voices shape decisions about healthcare
- rights and access - to integrate psoriasis into national NCD strategies, include essential medicines, and combat stigma.
About IFPA
IFPA (the International Federation of Psoriasis Associations), founded in 1971 and based in Stockholm, Sweden, is the global organization dedicated to advocating for everyone affected by psoriatic disease. IFPA's members include national and regional patient associations and represent over 60 million people worldwide. Through global coalitions, World Psoriasis Day campaigns, the IFPA Forum, and the World Psoriasis & Psoriatic Arthritis Conference, IFPA is redefining psoriatic disease as a key lens for stronger, more inclusive health systems.
https://www.ifpa-pso.com/
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
IFPA launches first Africa Forum on psoriasis calling for urgent action on overlooked disease
IFPA launches first Africa Forum on psoriasis calling for urgent action on overlooked disease
